Similar articles

• Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis.

  Alves TP, Wang X, Wright JT Jr, Appel LJ, Greene T, Norris K, Lewis J; AASK Collaborative Research Group. Alves TP, et al. J Am Soc Nephrol. 2010 Aug;21(8):1361-9. doi: 10.1681/ASN.2009060654. Epub 2010 Jul 22. J Am Soc Nephrol. 2010. PMID: 20651163 Free PMC article.
• The rationale and design of the AASK cohort study.

  Appel LJ, Middleton J, Miller ER 3rd, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT. Appel LJ, et al. J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S166-72. doi: 10.1097/01.asn.0000070081.15137.c0. J Am Soc Nephrol. 2003. PMID: 12819323
• RAAS blockade, renal failure, ESRD, and death among African Americans in the AASK Posttrial Cohort Study.

  Onuigbo MA. Onuigbo MA. Arch Intern Med. 2008 Nov 24;168(21):2383-4. doi: 10.1001/archinternmed.2008.510. Arch Intern Med. 2008. PMID: 19029505 No abstract available.
• African-Americans on maintenance dialysis: a review of racial differences in incidence, treatment, and survival.

  Price DA, Owen WF Jr. Price DA, et al. Adv Ren Replace Ther. 1997 Jan;4(1):3-12. doi: 10.1016/s1073-4449(97)70011-6. Adv Ren Replace Ther. 1997. PMID: 8996615 Review.
• Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma.

  Palmer Alves T, Lewis J. Palmer Alves T, et al. Clin Nephrol. 2010 Nov;74 Suppl 1:S72-7. doi: 10.5414/cnp74s072. Clin Nephrol. 2010. PMID: 20979968 Review.